loading

Galectin Therapeutics Inc (GALT) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
41.43%
4.625
7.897 12.43 9.066 11.29
Operating Income/Loss
41.43%
-4.625
-7.897 -12.43 -9.066 -11.29
Nonoperating Income/Loss
67.01%
-2.896
-1.734 0.461 -2.154 -1.08
Income/Loss From Continuing Operations Before Tax
21.91%
-7.521
-9.631 -11.97 -11.22 -12.37
Income/Loss From Continuing Operations After Tax
21.91%
-7.521
-9.631 -11.97 -11.22 -12.37
Net Income/Loss
21.91%
-7.521
-9.631 -11.97 -11.22 -12.37
Preferred Stock Dividends And Other Adjustments
342.31%
0.063
-0.026 0.063 0.018 0.064
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.38%
63.45
63.20 0.146 62.28 62.23
Diluted Average Shares
0.38%
63.45
63.20 0.146 62.28 62.23
Basic Earnings Per Share
20.00%
-0.12
-0.15 -0.19 -0.18 -0.20
Diluted Earnings Per Share
20.00%
-0.12
-0.15 -0.19 -0.18 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
342.31%
0.063
-0.026 0.063 0.018 0.064
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
大文字化:     |  ボリューム (24 時間):